Showa Denko K.K. Revises Consolidated Earnings Guidance for the Full Year Ending December 31, 2021
August 02, 2021 at 10:00 pm EDT
Share
Showa Denko K.K. revised consolidated earnings guidance for year ending December 31, 2021. For the year, the company revised net sales guidance of JPY 1,400,000 million compared to previous guidance of JPY 1,345,000 million. Revised operating income guidance of JPY 85,000 million compared to previous guidance of JPY 68,000 million. Revised net loss attributable to owners of the parent guidance of JPY 25,000 million compared to previous guidance of income of JPY 14,000 million. Revised net loss attributable to owners of the parent per share guidance of JPY 171.37 compared to previous guidance of income of JPY 95.97 per share.
Resonac Holding Corporation (formerly Showa Denko KK) is a holding company organized around 7 family of products:
- materials (43.8% of net sales): electronics materials (epoxy molding compounds, die bonding materials, CMP slurries, anisotropic conductive films), printed wiring board materials (copper-clad laminates, photosensitive dry films), mobility components (plastic molded products, friction materials, powder metal products, carbon anode materials for LIBs), energy storage devices and systems (automotive and industrial batteries), and life sciences (diagnostics, contracted manufacturing of regenerative medicine products);
- petrochemical products (19.6%): olefins (polyethylene, polypropylene) and organic chemical products (vinyl acetate monomer, ethyl acetate and plastics);
- chemical products (12.9%): caustic soda, chlorine, liquid ammonia, amino acids, polymers, gas (oxygen, nitrogen, hydrogen), etc.;
- electronic components (8.3%): hard disks, semiconductors components, magnetic components, etc.;
- inorganic products (7.1%): ceramics and carbons (graphite electrodes);
- aluminum products (5.3%): aluminum foils, extruded products, forged products, cans, etc.;
- other (3%).
Net sales break down geographically as follows: Japan (53.4%), China (12%), Asia (20.6%) and other (14%).